Despite the high incidence of diabetes, disease management remains elusive and the per patient costs have continued to escalate.
Clinical pathways for diabetes could grow by addressing cultural differences, low health literacy of patients and the need for innovative tools and products.
Clinical pathways provide an opportunity to aid the implementation of evidence-based practices for patients with diabetes in order to improve control of the disease, reduce the incidence of complications, and contain health care costs.
In this article, the authors review theories of change management and explore how they can be applied to the implementation of clinical pathways.
David Hughes, BSN, discusses how his institution uses a variety of criteria to target patients who might be eligible for clinical pathway inclusion.
The objective of this article is to review the strengths and limitations of commonly used methods for measuring adherence, describe the significance of a gold standard, and explore several candidates for this designation.
A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways
Researchers report on a novel patient-reported outcomes quality-of-life tool incorporated into a clinical pathway to see if patient well-being could be improved.
Associations Between Pre- and Post-Cancer Depression Diagnoses and End-of-Life Cancer Care Intensity
In a retrospective study, authors exaimed whether depression diagnoses were associated with end-of-life care intensity among elderly cancer decedents.
Authors present findings on the limited knowledge and misconceptions of health care providers regarding patient-centered medicine and patient-reported outcomes.
Dr Stepanski adds to the discussion on patient-reported outcomes in oncology with a counterpoint on the recent progress of these measures in trials and care settings.